
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
AI Summary
- About
908 Devices Inc (MASS)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
02/07/2025: MASS (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -56.2% | Avg. Invested days 25 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 94.72M USD | Price to earnings Ratio - | 1Y Target Price 5.33 |
Price to earnings Ratio - | 1Y Target Price 5.33 | ||
Volume (30-day avg) 947704 | Beta 0.98 | 52 Weeks Range 1.81 - 7.91 | Updated Date 02/21/2025 |
52 Weeks Range 1.81 - 7.91 | Updated Date 02/21/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.79 |
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -109.11% | Operating Margin (TTM) -70.56% |
Management Effectiveness
Return on Assets (TTM) -15.56% | Return on Equity (TTM) -40% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 28121743 | Price to Sales(TTM) 1.72 |
Enterprise Value 28121743 | Price to Sales(TTM) 1.72 | ||
Enterprise Value to Revenue 0.51 | Enterprise Value to EBITDA -3.15 | Shares Outstanding 34822800 | Shares Floating 26125136 |
Shares Outstanding 34822800 | Shares Floating 26125136 | ||
Percent Insiders 8.2 | Percent Institutions 64.36 |
AI Summary
Company Profile: 908 Devices Inc. is a leading provider of mass spectrometry solutions for chemical and biochemical analysis. The company was founded in 2012 with a mission to deliver innovative analytical tools that enable real-time measurements in complex samples. 908 Devices Inc. specializes in creating handheld and desktop mass spectrometry devices that provide rapid and accurate analysis in various industries, including life sciences, safety and security, and research.
The core business areas of 908 Devices Inc. include developing and manufacturing mass spectrometry instruments that are portable, easy to use, and offer high performance. The company's products are designed to deliver precise analytical results in diverse applications, such as drug detection, environmental monitoring, and food safety testing.
The leadership team of 908 Devices Inc. is comprised of industry experts with extensive experience in mass spectrometry technology and product development. The corporate structure of the company is organized around research and development, manufacturing, sales and marketing, and customer support divisions to ensure seamless operation and customer satisfaction.
Top Products and Market Share: Some of the top products offered by 908 Devices Inc. include the M908 Handheld Mass Spectrometer, MX908 Handheld Mass Spectrometer, and Rebelion Desktop Mass Spectrometer. These products are known for their compact size, high sensitivity, and real-time analysis capabilities, making them popular choices for field and laboratory applications.
In terms of market share, 908 Devices Inc. has been steadily increasing its presence in the global mass spectrometry market, particularly in the United States. The company's innovative products have gained recognition for their performance and reliability, leading to a growing customer base across various industries.
When compared to competitors in the mass spectrometry industry, 908 Devices Inc. stands out for its focus on portability, ease of use, and quick analysis time. The company's products have been well-received by customers who value convenience and efficiency in their analytical processes.
Total Addressable Market: The market that 908 Devices Inc. operates in, the mass spectrometry industry, is estimated to be worth billions of dollars globally. With increasing demand for analytical tools in various sectors, such as healthcare, environmental monitoring, and pharmaceuticals, the total addressable market for mass spectrometry devices continues to expand.
Financial Performance: In terms of financial performance, 908 Devices Inc. has shown consistent growth in recent years. The company's revenue has been increasing steadily, with strong profit margins and earnings per share. Year-over-year comparisons reflect a positive trend in financial health, supported by healthy cash flow statements and a robust balance sheet.
Dividends and Shareholder Returns: 908 Devices Inc. does not currently pay dividends to shareholders. However, the company has delivered solid shareholder returns over the years through capital appreciation and growth opportunities. Shareholder returns have been favorable over various time periods, reflecting the company's commitment to creating long-term value for investors.
Growth Trajectory: 908 Devices Inc. has demonstrated a strong growth trajectory over the past decade, marked by continuous product innovation and strategic initiatives. The company's recent product launches and partnerships have further fueled its growth prospects, positioning it as a key player in the mass spectrometry market. Future growth projections are positive, driven by industry trends and expanding market opportunities.
Market Dynamics: The mass spectrometry industry is characterized by technological advancements, increasing demand for analytical solutions, and evolving regulatory requirements. 908 Devices Inc. is well-positioned within the industry due to its focus on portable and user-friendly devices that cater to diverse customer needs. The company's adaptability to market changes and customer preferences is a key factor in its success.
Competitors: Key competitors of 908 Devices Inc. in the mass spectrometry industry include Thermo Fisher Scientific (TMO), Agilent Technologies (A), and Waters Corporation (WAT). While these competitors hold significant market share in the industry, 908 Devices Inc. differentiates itself through its innovative product offerings, customer-centric approach, and agility in responding to market trends.
Potential Challenges and Opportunities: One of the key challenges that 908 Devices Inc. faces is maintaining a competitive edge in a rapidly evolving market. The company must continue to innovate and expand its product portfolio to stay ahead of competitors. However, there are also significant opportunities for growth, including entering new markets, developing cutting-edge technologies, and forging strategic partnerships to drive expansion and revenue growth.
Recent Acquisitions (last 3 years): There have been no reported acquisitions by 908 Devices Inc. in the last three years.
AI-Based Fundamental Rating: Based on an AI-based rating system, 908 Devices Inc. receives a rating of 8 out of 10. This rating is supported by the company's strong financial performance, innovative products, competitive positioning, and growth potential in the mass spectrometry industry.
Sources and Disclaimers: Sources used for gathering data for this analysis include company reports, financial statements, industry publications, and market research reports. This information is provided for informational purposes only and should not be used as a sole basis for investment decisions. Investors are advised to conduct their own research and consult with financial advisors before making any investment choices.
About 908 Devices Inc
Exchange NASDAQ | Headquaters Boston, MA, United States | ||
IPO Launch date 2020-12-18 | Co-Founder, CEO, President & Director Dr. Kevin J. Knopp Ph.D. | ||
Sector Healthcare | Industry Medical Devices | Full time employees 230 | Website https://908devices.com |
Full time employees 230 | Website https://908devices.com |
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.